Verition Fund Management LLC Keros Therapeutics, Inc. Transaction History

Verition Fund Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$9.55 - $15.11 $1.25 Million - $1.97 Million	130,462 Added 315.88%	171,763 $2.29 Million
Q1 2025 May 15, 2025	SELL	$10.15 - $16.1 $1.77 Million - $2.81 Million	-174,802 Reduced 80.89%	41,301 $420,000
Q4 2024 Feb 14, 2025	BUY	$15.64 - $70.0 $3.38 Million - $15.1 Million	216,103 New	216,103 $3.42 Million

169

35.4M

574K

325K

Ticker KROS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,757,000
Market Cap $445M
Description
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.